Ekso Bionics Holdings, Inc. (EKSO)
USD 0.63
(-11.99%)
USD 0.63
(-11.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.16 Million USD | -4.49% |
| 2022 | 7.5 Million USD | 237.76% |
| 2021 | 2.22 Million USD | -42.38% |
| 2020 | 3.85 Million USD | -0.41% |
| 2019 | 3.87 Million USD | -22.26% |
| 2018 | 4.98 Million USD | -28.87% |
| 2017 | 7 Million USD | 2.34% |
| 2016 | 6.84 Million USD | 8453.75% |
| 2015 | 80 Thousand USD | -32.2% |
| 2014 | 118 Thousand USD | 1165.55% |
| 2013 | 9324.00 USD | 159.0% |
| 2012 | 3600.00 USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 5.35 Million USD | -5.16% |
| 2024 Q2 | 6.69 Million USD | -2.21% |
| 2024 Q1 | 6.84 Million USD | -4.55% |
| 2023 Q2 | 7.5 Million USD | -0.03% |
| 2023 Q4 | 7.16 Million USD | -4.22% |
| 2023 FY | 7.16 Million USD | -4.49% |
| 2023 Q1 | 7.5 Million USD | 0.0% |
| 2023 Q3 | 7.48 Million USD | -0.25% |
| 2022 Q1 | 2.09 Million USD | -5.9% |
| 2022 Q4 | 7.5 Million USD | 120.28% |
| 2022 Q3 | 3.4 Million USD | 57.73% |
| 2022 FY | 7.5 Million USD | 237.76% |
| 2022 Q2 | 2.16 Million USD | 3.3% |
| 2021 Q4 | 2.22 Million USD | -6.01% |
| 2021 Q1 | 3.72 Million USD | -3.48% |
| 2021 FY | 2.22 Million USD | -42.38% |
| 2021 Q3 | 2.36 Million USD | -5.63% |
| 2021 Q2 | 2.5 Million USD | -32.7% |
| 2020 Q3 | 3.85 Million USD | 0.1% |
| 2020 Q2 | 3.85 Million USD | 20.48% |
| 2020 FY | 3.85 Million USD | -0.41% |
| 2020 Q4 | 3.85 Million USD | -0.05% |
| 2020 Q1 | 3.19 Million USD | -17.38% |
| 2019 Q4 | 3.87 Million USD | -15.05% |
| 2019 FY | 3.87 Million USD | -22.26% |
| 2019 Q3 | 4.55 Million USD | -12.87% |
| 2019 Q2 | 5.23 Million USD | -10.95% |
| 2019 Q1 | 5.87 Million USD | 17.93% |
| 2018 Q2 | 6.11 Million USD | -8.16% |
| 2018 Q1 | 6.65 Million USD | -4.94% |
| 2018 Q4 | 4.98 Million USD | -10.53% |
| 2018 FY | 4.98 Million USD | -28.87% |
| 2018 Q3 | 5.56 Million USD | -8.95% |
| 2017 Q4 | 7 Million USD | 1.14% |
| 2017 Q1 | 6.87 Million USD | 0.5% |
| 2017 Q3 | 6.92 Million USD | 0.67% |
| 2017 FY | 7 Million USD | 2.34% |
| 2017 Q2 | 6.87 Million USD | 0.01% |
| 2016 Q1 | 81 Thousand USD | 1.25% |
| 2016 Q2 | 78 Thousand USD | -3.7% |
| 2016 Q4 | 6.84 Million USD | 10113.43% |
| 2016 Q3 | 67 Thousand USD | -14.1% |
| 2016 FY | 6.84 Million USD | 8453.75% |
| 2015 Q3 | 79 Thousand USD | -17.71% |
| 2015 Q2 | 96 Thousand USD | -10.28% |
| 2015 Q1 | 107 Thousand USD | -9.32% |
| 2015 FY | 80 Thousand USD | -32.2% |
| 2015 Q4 | 80 Thousand USD | 1.27% |
| 2014 Q4 | 118 Thousand USD | -8.63% |
| 2014 Q2 | 139.99 Thousand USD | -7.08% |
| 2014 Q1 | 150.66 Thousand USD | 1286.17% |
| 2014 FY | 118 Thousand USD | 1165.55% |
| 2014 Q3 | 129.14 Thousand USD | -7.75% |
| 2013 Q2 | 9324.00 USD | 0.0% |
| 2013 Q4 | 10.86 Thousand USD | 16.57% |
| 2013 FY | 9324.00 USD | 159.0% |
| 2013 Q1 | 9324.00 USD | -47.56% |
| 2013 Q3 | 9324.00 USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 3600.00 USD | 0.0% |
| 2012 Q4 | 17.78 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 91.637% |
| AngioDynamics, Inc. | 5.91 Million USD | -21.204% |
| AtriCure, Inc. | 74.49 Million USD | 90.378% |
| Avinger, Inc. | 15.39 Million USD | 53.439% |
| Azenta, Inc. | 60.43 Million USD | 88.14% |
| BioLife Solutions, Inc. | 42.69 Million USD | 83.21% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.721% |
| Daxor Corporation | 755.65 Thousand USD | -848.576% |
| Femasys Inc. | 6.7 Million USD | -6.971% |
| GlucoTrack, Inc. | 196 Thousand USD | -3557.143% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 83.242% |
| Hologic, Inc. | 2.53 Billion USD | 99.717% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.58% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 92.018% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -61.255% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 62.461% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 99.261% |
| Microbot Medical Inc. | 231 Thousand USD | -3003.03% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | 2.225% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 99.196% |
| Nephros, Inc. | 1.83 Million USD | -290.414% |
| NovoCure Limited | 596.24 Million USD | 98.798% |
| NEXGEL, Inc. | 2.79 Million USD | -156.183% |
| NEXGEL, Inc. | 2.79 Million USD | -156.183% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 90.479% |
| OraSure Technologies, Inc. | 13.5 Million USD | 46.919% |
| Pro-Dex, Inc. | 13.54 Million USD | 47.088% |
| Pulse Biosciences, Inc. | 9.14 Million USD | 21.61% |
| Predictive Oncology Inc. | 2.85 Million USD | -150.909% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -108.708% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.726% |
| Repligen Corporation | 711.8 Million USD | 98.993% |
| Sanara MedTech Inc. | 11.79 Million USD | 39.214% |
| STAAR Surgical Company | 35.83 Million USD | 79.997% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -1995.906% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.688% |
| Jin Medical International Ltd. | 4.11 Million USD | -74.277% |